Click here for printer-friendly version
* Medical enrollment grew to 34.9 million members, increasing by 774,000 members during the quarter * Net income was $1.26 per share, exceeding prior guidance * Operating cash flow totaled $2.0 billion, or 2.5 times net income * Full year 2007 earnings guidance raised to $5.54 per shareINDIANAPOLIS, April 25, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- WellPoint, Inc.
(NYSE: WLP) today announced that first quarter 2007 net income was $783.1
million, or $1.26 per share, representing 16 percent growth over the first
quarter of 2006. Net income in the first quarter of 2006 was $731.8 million,
or $1.09 per share, including $0.01 per share in net realized investment
losses.
"We are pleased to report a solid first quarter 2007 with earnings per
share that exceeded our prior guidance," said Larry C. Glasscock, chairman,
president and chief executive officer of WellPoint, Inc. "We had outstanding
commercial enrollment growth in the quarter, adding 586,000 National Account
members. National Account customers continue to be attracted by our superior
value proposition."
"We have seen industry leading membership growth because WellPoint offers
customers a unique combination of product breadth, flexibility and local
market presence," said Angela F. Braly, who will succeed Larry C. Glasscock as
president and chief executive officer of WellPoint, Inc. on June 1st. "We
aspire to transform health care and become the most valued company in our
industry by consistently delivering excellent service, the widest range of
product choices, and access to the highest quality care at the best value."
"Operating cash flow of $2.0 billion, or 2.5 times net income, was very
strong in the first quarter," said David C. Colby, vice chairman and chief
financial officer of WellPoint, Inc. "We continue to deploy cash flow to
maximize value for our shareholders. During the quarter, we repurchased 8.2
million shares of our common stock for $634.9 million. Our Board approved an
additional $2.0 billion in share repurchase authorization, bringing our total
authorization for 2007 to $3.0 billion, which we expect to utilize this year."
CONSOLIDATED HIGHLIGHTS
Membership: Medical enrollment totaled 34.9 million members at March 31,
2007, an increase of 717,000 members from 34.2 million reported at March 31,
2006. The increase was driven by National Accounts and State Sponsored
business, which added 621,000 members and 340,000 members, respectively, over
the last twelve months. Growth from the prior year in State Sponsored
business excludes the impact of the change in the Company's 50 percent
ownership interest in a joint venture in Puerto Rico to a smaller percentage
ownership in the joint venture's parent company. Accordingly, the Company no
longer includes the 222,000 members related to this investment in its
enrollment. Membership in consumer-directed health plans also increased by
57.1 percent in the past twelve months, now totaling 1.1 million members.
This growth was partially offset by declines in Local Group and Individual
business.
During the first quarter of 2007, medical enrollment grew by 774,000
members, led primarily by growth in National Accounts. National Account
employers are increasingly attracted to the benefits of WellPoint's
distinctive value proposition, which includes extensive and cost-effective
provider networks and a broad and innovative product portfolio. Also during
the quarter, the Company began Medicaid operations in Indiana and Kansas and
had continued growth in other State Sponsored geographies.
Operating Revenue: Operating revenue was $14.8 billion in the first
quarter of 2007, an increase of 8.8 percent from $13.6 billion in the prior
year first quarter. The increase resulted primarily from premium rate
increases in Local Group business, growth in the Medicare Advantage business,
having additional Part D members for the entire first quarter in 2007,
increased reimbursement in the Federal Employee Program ("FEP"), and higher
State Sponsored membership.
Benefit Expense Ratio: The benefit expense ratio was 83.1 percent in the
first quarter of 2007, a 180 basis point increase compared with 81.3 percent
in the first quarter of 2006, with the largest portion of the increase
attributable to the medical business of the Specialty, Senior, and State
Sponsored business segment.
The benefit expense ratio in the Company's Senior business increased by
350 basis points from the prior year quarter, mostly due to Medicare Part D.
As expected, Medicare Part D has a significantly higher benefit expense ratio
in the early part of the year, before members reach the coverage "doughnut
hole," and a much lower benefit expense ratio later in the year. This
seasonality of the Medicare Part D business was more pronounced in the first
quarter of 2007, as the majority of the membership was effective for a full
quarter this year, while the 2006 membership was gradually enrolled during the
first five months of 2006. Also, certain Part D claims in 2006 were incurred
in the first quarter, but not recorded until the fourth quarter (i.e., claims
from State Medicaid programs), due to the CMS reconciliation process.
Increases in State Sponsored claims experience in certain geographies
caused the benefit expense ratio to increase by 630 basis points in that line
of business between the first quarters of 2006 and 2007. Benefit expense
ratios were unacceptably high in two states, neither of which is among the
five new states the Company began serving during the past year. The Company
has negotiated rate increases in two California counties and anticipates
receiving rate increases in the remaining California counties effective
October 1, 2007. The Company also anticipates a rate increase in the other
state effective July 1, 2007. Additionally, the Company has implemented
numerous cost of care initiatives to improve financial performance in these
geographies. The Company remains disciplined in its pricing and will take
appropriate action if acceptable reimbursement cannot be obtained.
The Company's Commercial and Consumer business recognized an increase in
its benefit expense ratio due primarily to the timing of prior period
development in 2006, and this also unfavorably impacted the consolidated
benefit expense ratio. Excluding the impact of those prior period
developments, the benefit expense ratio declined slightly.
Continued growth in the Company's FEP business, for which the Company is
reimbursed for its costs plus a fee, also caused the consolidated benefit
expense ratio to increase as this business operates with a benefit expense
ratio higher than the Company average.
Due to adjusted estimates and expected actions in our State Sponsored
businesses through 2007, the Company now expects the benefit expense ratio to
be 81.9 percent for the year, which is 40 basis points higher than prior
guidance.
Premium and Cost Trends: Trends include Local Group and Individual
fully-insured businesses.
For the rolling 12-month period ended March 31, 2007, the primary drivers
of medical trend were inpatient and outpatient costs. The Company continues
to price its commercial business so that expected premium yield exceeds total
cost trend, where total cost trend includes medical costs and selling, general
and administrative ("SG&A") expense.
Based on medical trends in the first quarter 2007, the Company remains
comfortable with its 2007 medical cost trend estimate of less than 8.0
percent.
SG&A Expense Ratio: The SG&A expense ratio was 14.4 percent in the first
quarter of 2007, a decrease of 150 basis points from 15.9 percent in the first
quarter of 2006. The ratio improved year-over-year as the Company spread
administrative expenses across a growing revenue base, continued to control
expenses, and postponed discretionary spending due to higher claims
seasonality in the quarter.
Since the Company postponed certain discretionary spending until later in
the year due to the higher first quarter claims seasonality, the SG&A expense
ratio is expected to increase during the remainder of 2007, and be 14.6
percent for the year.
Operating Cash Flow: For the three months ended March 31, 2007, operating
cash flow totaled $2.0 billion, or 2.5 times net income. The results included
the receipt of an additional CMS payment totaling $429.2 million related to
the second quarter of 2007. Excluding this additional CMS payment, the first
quarter operating cash flow was 2.0 times net income.
Days in Claims Payable: Days in claims payable as of March 31, 2007, was
44.7 days, a decrease of 0.5 days from 45.2 days as of December 31, 2006. The
decline was primarily due to the timing of medical claim payments and the
payment of provider settlements related to 2006, which were partially offset
by the timing of claim payments in the pharmacy benefit management ("PBM")
operation.
Share Repurchase Program: During the first quarter 2007, the Company
repurchased 8.2 million shares of its common stock for $634.9 million. Also
during the quarter, the Board of Directors increased the share repurchase
authorization from $1.0 billion to $3.0 billion for the year. As of March 31,
2007, the Company's remaining Board-approved share repurchase authorization
was $2.3 billion. The Company intends to utilize the remaining authorization
during 2007, subject to market conditions. At March 31, 2007, cash and
investments held at the parent company and available for general corporate use
totaled $2.5 billion.
REPORTABLE SEGMENTS
In 2007, WellPoint, Inc. now has the following reportable segments:
Commercial and Consumer Business ("CCB"), Specialty, Senior, and State
Sponsored business ("4SB"), and Other, which includes FEP business, National
Government Services, Inc., intersegment sales and expense eliminations, and
corporate expenses not allocated to the other reportable segments. These
revised segments are consistent with the Company's new organizational
structure.
Operating revenue and operating gain are the key measures used by
management to evaluate performance in each segment.
WellPoint, Inc.
Reportable Segment Highlights
(Unaudited)
Three Months Ended
(In millions) March 31, December 31, September 30, June 30, March 31,
2007 2006 2006 2006 2006
Operating
Revenue
CCB $10,417.8 $10,321.7 $10,215.1 $10,148.4 $9,917.4
4SB 3,334.4 3,015.4 2,912.7 2,843.4 2,781.6
Other:
External
Customers 1,468.0 1,387.9 1,467.1 1,319.1 1,267.7
Intersegment
Eliminations (387.8) (381.6) (372.9) (349.4) (333.2)
Total Other 1,080.2 1,006.3 1,094.2 969.7 934.5
Total Operating
Revenue 14,832.4 14,343.4 14,222.0 13,961.5 13,633.5
Operating Gain
(Loss)
CCB $1,013.8 $854.7 $936.4 $906.3 $982.1
4SB 143.2 379.7 284.3 287.0 166.0
Other 16.3 (12.7) (13.1) (21.2) (12.6)
Operating Margin
CCB 9.7% 8.3% 9.2% 8.9% 9.9%
4SB 4.3% 12.6% 9.8% 10.1% 6.0%
Commercial and Consumer Business: Operating gain for the CCB segment was
$1,013.8 million in the first quarter of 2007, an increase of 3.2 percent,
compared with $982.1 million in the first quarter of 2006. The year-over-year
improvement was primarily due to premium rate increases across all lines of
business and continued overhead expense control, which were partially offset
by a higher benefit expense ratio.
Specialty, Senior, and State Sponsored Business: Operating gain for the
4SB segment totaled $143.2 million in the first quarter of 2007, a decrease of
13.7 percent compared with $166.0 million in the first quarter of 2006. The
decrease resulted primarily from higher benefit expenses in the Company's
Senior businesses and increases in State Sponsored claims experience in
certain geographies, which were partially offset by increased mail order
volume.
Other: Operating gain for the Other segment totaled $16.3 million in the
first quarter of 2007, an increase from the operating loss of $12.6 million in
the first quarter of 2006. The improvement resulted primarily from lower
corporate expenses and continued growth in FEP business, for which the Company
is reimbursed for its costs plus a fee.
OUTLOOK
Full Year 2007:
* The Company now expects net income of $5.54 per share, representing
growth of 15% over 2006.
* Year-end medical enrollment is expected to be approximately 35.5 million
members, representing growth for the year of 1.4 million members, or
4.0 percent.
* Operating revenue is now expected to total approximately $61.1 billion.
* The benefit expense ratio is now expected to be approximately
81.9 percent.
* The SG&A expense ratio is expected to be approximately 14.6 percent.
* The Company expects operating cash flow to exceed $4.4 billion, or
1.3 times net income.
Second Quarter 2007:
* The Company continues to expect net income of $1.35 per share,
consistent with prior guidance.
Basis of Presentation
1. Operating gain is defined as operating revenue less benefit expense,
selling expense, general and administrative expense, and cost of drugs.
Operating gain is used to analyze profit or loss on a segment basis.
Consolidated operating gain is a non-GAAP measure.
2. Operating margin is defined as operating gain divided by operating
revenue.
3. The Company revised its reportable segments and customer types in the
first quarter of 2007 in accordance with its new organizational
structure.
4. Certain prior period amounts have been reclassified to conform to
current period presentation.
Conference Call and Webcast
Management will host a conference call and webcast today at 8:30 a.m.
Eastern Daylight Time ("EDT") to discuss its first quarter earnings results.
The conference call should be accessed at least 15 minutes prior to the start
of the call with the following numbers:
888-423-3268 (Domestic) 800-475-6701 (Domestic Replay)
651-291-5254 (International) 320-365-3844 (International Replay)
An access code is not required for today's conference call. The access
code for the replay is 857269. The replay will be available from
1:45 p.m. EDT today until the end of the day on May 9, 2007. The call will
also be available through a live webcast at www.wellpoint.com under "Investor
Info." A webcast replay will be available following the call.
About WellPoint, Inc.
WellPoint's mission is to improve the lives of the people it serves and
the health of its communities. WellPoint, Inc. is the largest health benefits
company in terms of commercial membership in the United States. Through its
nationwide networks, the company delivers a number of leading health benefit
solutions through a broad portfolio of integrated health care plans and
related services, along with a wide range of specialty products such as life
and disability insurance benefits, pharmacy benefit management, dental,
vision, behavioral health benefit services, as well as long term care
insurance and flexible spending accounts. Headquartered in Indianapolis,
Indiana, WellPoint is an independent licensee of the Blue Cross and Blue
Shield Association and serves its members as the Blue Cross licensee for
California; the Blue Cross and Blue Shield licensee for Colorado, Connecticut,
Georgia, Indiana, Kentucky, Maine, Missouri (excluding 30 counties in the
Kansas City area), Nevada, New Hampshire, New York (as Blue Cross Blue Shield
in 10 New York City metropolitan and surrounding counties and as Blue Cross or
Blue Cross Blue Shield in selected upstate counties only), Ohio, Virginia
(excluding the Northern Virginia suburbs of Washington, D.C.), Wisconsin; and
through UniCare. Additional information about WellPoint is available at
www.wellpoint.com.
WellPoint, Inc.
Medical Membership & Specialty Metrics Summary
(Unaudited and in Thousands)
Change from
March 31, December 31, March 31, December 31, March 31,
Medical Membership 2007 2006 2006 2006 2006
Customer Type
Local Group (1) 16,689 16,766 16,742 (0.5%) (0.3%)
Individual 2,474 2,488 2,508 (0.6%) (1.4%)
National
Accounts (1) 6,479 6,136 6,209 5.6% 4.3%
BlueCard 4,522 4,279 4,171 5.7% 8.4%
Total National 11,001 10,415 10,380 5.6% 6.0%
Senior 1,238 1,193 1,200 3.8% 3.2%
State
Sponsored (2) 2,091 1,882 1,973 11.1% 6.0%
FEP 1,382 1,357 1,355 1.8% 2.0%
Total 34,875 34,101 34,158 2.3% 2.1%
Funding Arrangement
Self-Funded 17,483 16,745 16,997 4.4% 2.9%
Fully-Insured 17,392 17,356 17,161 0.2% 1.3%
Total 34,875 34,101 34,158 2.3% 2.1%
Reportable Segment
Commercial &
Consumer Business 30,164 29,669 29,630 1.7% 1.8%
Senior & State
Sponsored 3,329 3,075 3,173 8.3% 4.9%
Other 1,382 1,357 1,355 1.8% 2.0%
Total 34,875 34,101 34,158 2.3% 2.1%
Specialty Metrics
PBM Prescription
Volume (3) 101,127 95,685 109,756 5.7% (7.9%)
Behavioral Health
Membership 17,110 16,937 16,065 1.0% 6.5%
Life and Disability
Membership 5,916 5,970 5,920 (0.9%) (0.1%)
Dental Membership 5,196 5,270 5,256 (1.4%) (1.1%)
Vision Membership 2,277 1,536 907 48.2% 151.0%
Medicare Part D
Membership (4) 1,590 1,568 1,299 1.4% 22.4%
(1) Effective January 1, 2007, WellPoint revised its definition of a
National Account to include multi-state employers primarily
headquartered in a WellPoint service area with 1,000 or more eligible
employees, of which at least 5% or more are located in a service area
outside of the headquarter's state.
(2) During the fourth quarter of 2006, the Company's ownership of a joint
venture in Puerto Rico changed from a 50 percent ownership of a
Medicaid managed care subsidiary to a smaller percentage ownership in
the joint venture's parent company. Accordingly, for December 31, 2006
and subsequent periods, the Company no longer includes the 222,000
members related to this investment in its reported enrollment.
(3) Represents quarterly prescription volume at the Company's PBM
operation.
(4) Includes auto-assigned, stand-alone, Medicare Advantage, group waiver
and external PBM members with the prescription drug plan benefit.
WellPoint, Inc.
Consolidated Statements of Income
(Unaudited)
Three Months Ended
(In millions, except per share data) March 31
2007 2006 Change
Revenues
Premiums $13,757.4 $12,578.9 9.4%
Administrative fees 924.8 902.8 2.4%
Other revenue 150.2 151.8 (1.1%)
Total operating revenue 14,832.4 13,633.5 8.8%
Net investment income 246.6 212.1 16.3%
Net realized gains (losses) on
investments 0.2 (7.1) -
Total revenues 15,079.2 13,838.5 9.0%
Expenses
Benefit expense 11,429.5 10,225.0 11.8%
Selling, general and administrative
expense
Selling expense 423.0 401.4 5.4%
General and administrative expense 1,708.6 1,771.2 (3.5%)
Total selling, general and
administrative expense 2,131.6 2,172.6 (1.9%)
Cost of drugs 98.0 100.4 (2.4%)
Interest expense 102.9 94.0 9.5%
Amortization of other intangible assets 70.8 73.8 (4.1%)
Total expenses 13,832.8 12,665.8 9.2%
Income before income taxes 1,246.4 1,172.7 6.3%
Income taxes 463.3 440.9 5.1%
Net income $783.1 $731.8 7.0%
Net income per diluted share $1.26 $1.09 15.6%
Diluted shares 623.0 669.3 (6.9%)
Benefit expense as a percentage of premiums 83.1% 81.3% 180 bp
Selling, general and administrative expense
as a percentage of total operating revenue 14.4% 15.9% (150)bp
Income before income taxes as a percentage
of total revenues 8.3% 8.5% (20)bp
WellPoint, Inc.
Consolidated Balance Sheets
March 31, December 31,
(In millions) 2007 2006
(Unaudited)
Assets
Current assets:
Cash and cash equivalents $3,402.0 $2,602.1
Investments available-for-sale, at
fair value 3,731.7 2,449.9
Other invested assets, current 49.5 72.8
Accrued investment income 162.2 157.2
Premium and self-funded receivables 2,790.4 2,520.2
Other receivables 1,145.8 1,172.7
Securities lending collateral 753.3 904.7
Deferred tax assets, net 665.5 642.6
Other current assets 1,318.0 1,284.5
Total current assets 14,018.4 11,806.7
Long-term investments available-for-sale,
at fair value 14,575.5 15,058.6
Other invested assets, long-term 641.3 628.8
Property and equipment, net 979.2 988.6
Goodwill 13,449.6 13,383.5
Other intangible assets 9,325.4 9,396.2
Other noncurrent assets 499.8 497.4
Total assets $53,489.2 $51,759.8
Liabilities and shareholders' equity
Liabilities
Current liabilities:
Policy liabilities:
Medical claims payable $5,671.3 $5,290.3
Reserves for future policy benefits 78.6 76.3
Other policyholder liabilities 2,323.7 2,240.6
Total policy liabilities 8,073.6 7,607.2
Unearned income 1,655.8 987.9
Accounts payable and accrued expenses 2,787.9 3,242.2
Income taxes payable 314.3 538.2
Security trades pending payable 138.8 124.8
Securities lending payable 753.3 904.7
Current portion of long-term debt 520.9 521.0
Other current liabilities 1,510.6 1,397.4
Total current liabilities 15,755.2 15,323.4
Long-term debt, less current portion 6,585.6 6,493.2
Reserves for future policy benefits,
noncurrent 642.1 646.9
Deferred tax liability, net 3,117.6 3,350.2
Other noncurrent liabilities 2,249.3 1,370.3
Total liabilities 28,349.8 27,184.0
Shareholders' equity
Common stock 6.1 6.1
Additional paid-in capital 19,959.9 19,863.5
Retained earnings 5,071.1 4,656.1
Accumulated other comprehensive income (loss) 102.3 50.1
Total shareholders' equity 25,139.4 24,575.8
Total liabilities and shareholders' equity $53,489.2 $51,759.8
WellPoint, Inc.
Consolidated Statements of Cash Flows
(Unaudited)
Three Months Ended March 31
(In millions) 2007 2006
Operating activities
Net income $783.1 $731.8
Adjustments to reconcile net income
to net cash provided by operating activities:
Net realized (gains) losses
on investments (0.2) 7.1
Loss (gain) on disposal of assets 0.2 (1.4)
Deferred income taxes (97.1) 101.6
Amortization, net of accretion 112.4 113.5
Depreciation expense 31.7 34.9
Share-based compensation 40.3 54.6
Excess tax benefits from
share-based compensation (51.2) (36.3)
Changes in operating assets and
liabilities, net of effect of
business combinations:
Receivables, net (209.0) (236.5)
Other invested assets, current 23.4 (122.0)
Other assets (36.7) (164.8)
Policy liabilities 463.6 520.0
Unearned income 667.9 578.2
Accounts payable and accrued
expenses (319.0) (103.2)
Other liabilities 74.6 116.7
Income taxes 500.2 203.4
Other, net (3.1) -
Net cash provided by operating activities 1,981.1 1,797.6
Investing activities
Purchases of fixed maturity securities (2,417.9) (4,933.9)
Proceeds from sales and maturities of
fixed maturity securities 1,561.1 4,233.5
Purchase of equity securities (375.1) (700.2)
Proceeds from sales of equity securities 484.3 648.9
Changes in securities lending collateral 151.4 198.7
Purchases of property and equipment (56.6) (36.4)
Proceeds from sales of property and equipment - 1.4
Other, net (9.4) (24.7)
Net cash used in investing activities (662.2) (612.7)
Financing activities
Net proceeds from (repayments of)
commercial paper borrowings 91.9 (606.7)
Proceeds from long-term borrowings - 2,668.9
Repayment of long-term borrowings (2.2) (1,703.8)
Changes in securities lending payable (151.4) (198.7)
Changes in bank overdrafts (135.6) (266.2)
Repurchase and retirement of common stock (634.9) (1,912.0)
Proceeds from exercise of employee stock
options and employee stock purchase plan 262.0 197.1
Excess tax benefits from share-based
compensation 51.2 36.3
Net cash used in financing activities (519.0) (1,785.1)
Change in cash and cash equivalents 799.9 (600.2)
Cash and cash equivalents at
beginning of period 2,602.1 2,740.2
Cash and cash equivalents at end of period $3,402.0 $2,140.0
WellPoint, Inc.
Operating Cash Flow as a Multiple of Net Income
(Unaudited)
(In millions) Three Months Ended March 31, 2007 (1)
Additional CMS
As Reported Monthly Payment Adjusted
Operating cash flow $1,981.1 $429.2 $1,551.9
Net Income $783.1 - $783.1
Operating cash flow as a
multiple of net income 2.5 - 2.0
(1) Operating cash flow for the three months ended March 31, 2007,
included the receipt of an additional CMS payment totaling $429.2
million that relates to the second quarter of 2007. If the Company
had not received the additional CMS payment during the quarter,
operating cash flow would have been 2.0 times net income. Due to the
magnitude of these payments, the Company has presented the "Operating
Cash Flow as a Multiple of Net Income" metric on an adjusted basis
(which excludes the additional payment from the first quarter 2007
operating cash flow) in order to facilitate period-to-period
analysis.
WellPoint, Inc.
Medical Membership & Specialty Metrics Summary - Historical Resegmented
(Unaudited and in Thousands)
December 31, September 30, June 30, March 31, December 31,
Medical 2006 2006 2006 2006 2005
Membership
Customer Type
Local Group (1) 16,766 16,665 16,701 16,742 17,274
Individual 2,488 2,508 2,508 2,508 2,526
National
Accounts (1) 6,136 6,225 6,217 6,209 5,632
BlueCard 4,279 4,214 4,194 4,171 3,916
Total National 10,415 10,439 10,411 10,380 9,548
Senior 1,193 1,195 1,209 1,200 1,174
State Sponsored (2) 1,882 2,027 1,980 1,973 1,989
FEP 1,357 1,356 1,354 1,355 1,345
Total 34,101 34,190 34,163 34,158 33,856
Funding Arrangement
Self-Funded 16,745 16,937 16,980 16,997 16,584
Fully-Insured 17,356 17,253 17,183 17,161 17,272
Total 34,101 34,190 34,163 34,158 33,856
Reportable Segment
Commercial &
Consumer Business 29,669 29,612 29,620 29,630 29,348
Senior & State
Sponsored 3,075 3,222 3,189 3,173 3,163
Other 1,357 1,356 1,354 1,355 1,345
Total 34,101 34,190 34,163 34,158 33,856
Specialty Metrics
PBM Prescription
Volume (3) 95,685 90,308 96,919 109,756 91,804
Behavioral Health
Membership 16,937 16,048 15,938 16,065 15,669
Life and Disability
Membership 5,970 5,956 5,964 5,920 5,826
Dental Membership 5,270 5,193 5,258 5,256 5,195
Medicare Part D
Membership (4) 1,568 1,569 1,527 1,299 -
Vision Membership 1,536 1,255 940 907 816
(1) Effective January 1, 2007, WellPoint revised its definition of a
National Account to include multi-state employers primarily
headquartered in a WellPoint service area with 1,000 or more eligible
employees, of which at least 5% or more are located in a service area
outside of the headquarter's state.
(2) During the fourth quarter of 2006, the Company's ownership of a joint
venture in Puerto Rico changed from a 50 percent ownership of a
Medicaid managed care subsidiary to a smaller percentage ownership in
the joint venture's parent company. Accordingly, for December 31, 2006
and subsequent periods, the Company no longer includes the 222,000
members related to this investment in its reported enrollment.
(3) Represents quarterly prescription volume at the Company's PBM
operation.
(4) Includes auto-assigned, stand-alone, Medicare Advantage, group waiver
and external PBM members with the prescription drug plan benefit.
SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES
LITIGATION REFORM ACT OF 1995
This press release contains certain forward-looking information about
WellPoint, Inc. ("WellPoint") that is intended to be covered by the safe
harbor for "forward-looking statements" provided by the Private Securities
Litigation Reform Act of 1995. Forward-looking statements are statements that
are not historical facts. Words such as "expect(s)", "feel(s)", "believe(s)",
"will", "may", "anticipate(s)" and similar expressions are intended to
identify forward-looking statements. These statements include, but are not
limited to, financial projections and estimates and their underlying
assumptions; statements regarding plans, objectives and expectations with
respect to future operations, products and services; and statements regarding
future performance. Such statements are subject to certain risks and
uncertainties, many of which are difficult to predict and generally beyond the
control of WellPoint, that could cause actual results to differ materially
from those expressed in, or implied or projected by, the forward-looking
information and statements. These risks and uncertainties include: those
discussed and identified in public filings with the U.S. Securities and
Exchange Commission ("SEC") made by WellPoint; trends in health care costs and
utilization rates; our ability to secure sufficient premium rate increases;
competitor pricing below market trends of increasing costs; increased
government regulation of health benefits, managed care and pharmacy benefit
management operations; risks and uncertainties regarding the Medicare Part D
Prescription Drug benefits program, including potential uncollectability of
receivables resulting from processing and/or verifying enrollment (including
facilitated enrollment), inadequacy of underwriting assumptions, inability to
receive and process information, uncollectability of premium from members,
increased pharmaceutical costs, and the underlying seasonality of the
business; significant acquisitions or divestitures by major competitors;
introduction and utilization of new prescription drugs and technology; a
downgrade in our financial strength ratings; litigation and investigations
targeted at health benefits companies and our ability to resolve litigation
and investigations within estimates; our ability to contract with providers
consistent with past practice; other potential uses of cash in the future that
present attractive alternatives to share repurchases; our ability to achieve
expected synergies and operating efficiencies in the WellChoice, Inc.
acquisition within the expected time frames or at all, and to successfully
integrate our operations; our ability to meet expectations regarding
repurchases of shares of our common stock; future bio-terrorist activity or
other potential public health epidemics; and general economic downturns.
Readers are cautioned not to place undue reliance on these forward-looking
statements that speak only as of the date hereof. WellPoint does not undertake
any obligation to republish revised forward-looking statements to reflect
events or circumstances after the date hereof or to reflect the occurrence of
unanticipated events. Readers are also urged to carefully review and consider
the various disclosures in WellPoint's various SEC reports, including but not
limited to WellPoint's Annual Report on Form 10-K for the year ended December
31, 2006.
SOURCE WellPoint, Inc.
Investor Relations, Wayne DeVeydt, +1-317-488-6390, or Media, Jim Kappel,
+1-317-488-6400, both of WellPoint, Inc.